Ir-UA
Ir-UA is an usnic acid-derived iridium (III) complex that enhances PD-L1 expression and converts "cold tumors" into "hot tumors." Ir-UA stimulates PD-L1 expression by explicitly regulating the PD-L1 transcription factor[1].
Product Specifications
CAS Number
3033235-42-3
UNSPSC
12352211
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ir-ua.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(O)=C2C(C)(C(OC2=C1C(C)=O)=CC/3=O)C(C3=C(C)\NCC4=CC=[N](C(C5=[N]6C=CC(C)=C5)=C4)[Ir+3]786(C9=CC=CC=C9C%10=[N]8C=CC=C%10)[N]%11=CC=CC=C%11C%12=CC=CC=C%127)=O)C.[F-][P+5]([F-])([F-])([F-])([F-])[F-]
Molecular Formula
C52H43F6IrN5O6P 2+
Molecular Weight
1171.11
References & Citations
[1]Deng D, et al. Iridium (III) -Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy. J Med Chem. 2024 Apr 25;67 (8) :6810-6821.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
042890 200 µL
TM165, NT (TMEM165, TPARL, Transmembrane protein 165, Transmembrane protein PT27, Transmembrane protein TPARL)
Sign In for Pricing
View Details